ATE240749T1 - Radioaktivmarkierte annexin-galaktose konjugate - Google Patents
Radioaktivmarkierte annexin-galaktose konjugateInfo
- Publication number
- ATE240749T1 ATE240749T1 AT95923885T AT95923885T ATE240749T1 AT E240749 T1 ATE240749 T1 AT E240749T1 AT 95923885 T AT95923885 T AT 95923885T AT 95923885 T AT95923885 T AT 95923885T AT E240749 T1 ATE240749 T1 AT E240749T1
- Authority
- AT
- Austria
- Prior art keywords
- radioactive labeled
- labeled annexin
- conjugates
- galactose conjugates
- galactose
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/088—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins conjugates with carriers being peptides, polyamino acids or proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/547—Chelates, e.g. Gd-DOTA or Zinc-amino acid chelates; Chelate-forming compounds, e.g. DOTA or ethylenediamine being covalently linked or complexed to the pharmacologically- or therapeutically-active agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/087—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the peptide being an annexin, e.g. annexin V
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US26106494A | 1994-06-16 | 1994-06-16 | |
PCT/US1995/007599 WO1995034315A1 (en) | 1994-06-16 | 1995-06-13 | Radiolabeled annexin-galactose conjugates |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE240749T1 true ATE240749T1 (de) | 2003-06-15 |
Family
ID=22991800
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT95923885T ATE240749T1 (de) | 1994-06-16 | 1995-06-13 | Radioaktivmarkierte annexin-galaktose konjugate |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1364964A1 (de) |
AT (1) | ATE240749T1 (de) |
CA (1) | CA2185349C (de) |
DE (1) | DE69530841T2 (de) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5627036A (en) * | 1989-12-27 | 1997-05-06 | Boehringer Ingelheim International Gmbh | Use of an anticoagulant as a diagnostic agent |
AU642202B2 (en) * | 1989-12-27 | 1993-10-14 | Boehringer Ingelheim International Gmbh | Use of an anticoagulant as a diagnostic agent |
US5552525A (en) * | 1991-02-08 | 1996-09-03 | Diatech Inc. | Technetium-99m labeled peptides for imaging inflammation |
EP0538459A4 (en) * | 1991-05-09 | 1993-06-16 | The Board Of Regents Of The University Of Washington | Phospholipid-targeted thrombolytic agents |
US6323313B1 (en) * | 1999-06-01 | 2001-11-27 | The University Of Washington | Annexin derivative with endogenous chelation sites |
WO2002080754A2 (en) * | 2001-04-03 | 2002-10-17 | Theseus Imaging Corporation | Methods for using annexin for detecting cell death in vivo and treating associated conditions |
-
1995
- 1995-06-13 CA CA2185349A patent/CA2185349C/en not_active Expired - Fee Related
- 1995-06-13 DE DE69530841T patent/DE69530841T2/de not_active Expired - Lifetime
- 1995-06-13 AT AT95923885T patent/ATE240749T1/de not_active IP Right Cessation
- 1995-06-13 EP EP03011344A patent/EP1364964A1/de not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
DE69530841T2 (de) | 2004-05-06 |
EP1364964A1 (de) | 2003-11-26 |
CA2185349C (en) | 2010-04-20 |
CA2185349A1 (en) | 1995-12-21 |
DE69530841D1 (de) | 2003-06-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE261317T1 (de) | Radioaktiv markierte annexine | |
NO931631L (no) | Kompleksdannende midler og maalsoeking av radioaktive immunoreagenser nyttige innen terapeutiske og diagnostiske bildedannende sammensetninger og fremgangsmetoder | |
DE69102600T2 (de) | Diffusionsschweissrepariertechnik. | |
PT809996E (pt) | Conjugados de interferao | |
DE69711686D1 (de) | Molybdänkomplexe enthaltende schmiermittelzusammensetzungen | |
EP0765166A4 (de) | Radioaktivmarkierte annexin-galaktose konjugate | |
DE69114050T2 (de) | Kugelgelenk für Prothese. | |
FI950346A (fi) | Menetelmä tioeetterikonjugaattien valmistamiseksi | |
ATE237366T1 (de) | Radioaktiv-markierte annexine | |
DE69713655D1 (de) | Drehbucheditor | |
DE59101892D1 (de) | Etikettiermaschine. | |
CA2206274A1 (en) | Radiolabeled annexin-galactose cluster conjugates | |
DE69108092T2 (de) | Elektronenstrahlschweissen. | |
DE69110750D1 (de) | Zytotoxisches Testverfahren. | |
DE69110918D1 (de) | Elektronenstrahlbestrahlungsapparat. | |
ATE240749T1 (de) | Radioaktivmarkierte annexin-galaktose konjugate | |
DE69516071D1 (de) | Elektronenquelle | |
TR199600667A2 (tr) | Tasit yatagi klavuz ray tertibati. | |
DE59004921D1 (de) | Spannvorrichtung. | |
FI913819A0 (fi) | Immunogena konjugat av icke-toxisk oligosackarid fraon bordetella pertussis -lipo-oligosackarider. | |
NO881635D0 (no) | Vinylsubstituerte radioaktive halogenkonjugater for proteinmerking. | |
EP1486509A3 (de) | Radioaktivmarkierte Annexin-Galaktose Konjugate | |
KR910019006U (ko) | 정류자 조립용 지그 | |
DE69123256T2 (de) | Antigen-antikörperkonjugaten | |
KR970027799U (ko) | 부품지지용 지그 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |